This work was supported by the National Key Research and Development Program of China(No.2020YFC2002706);the Key Military Health Project(No.23BJZ25).
Immune checkpoint inhibitors(ICIs)are employed in immunotherapeutic applications for patients with weakened immune systems and can improve the ability of T cells to kill cancer cells.Although ICIs can potentially trea...